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ABSTRACT
Objective: This study aimed to investigate the interactions of DNA methyltransferase (DNMT) enzymes and potential ligands as DNMT inhibitors 
through molecular dynamics simulations.
Methods: This study was conducted using tools in the form of hardware (primary and secondary computers) and software (OpenBabel, AutoDock 
Tools, Amber MD, Amber Tools, VMD, PuTTY, LigandScout, and UCSF Chimera).
Results: Results of molecular docking of cassiamin C, procyanidin B2, epicatechin-4alphaent-8-ent-epicatechin, epicatechin-4beta-8-epicatechin-
3-O-gallate, neorhusflavanone, 3-O-galloylepigallocatechin -4beta-6-epicatechin-3-O-gallate, withanolide, 3-O-galloylepigallocatechin-4beta-6-
epigallocatechin-3-O-gallate, cyanidin-3-6″-caffeylsophoroside-5-glucoside, epifriedelinol, gallocatechin-4alpha-8-epicatechin, scutellarein-7-
glucosyl-1-4-rhamnoside, epigallocatechin-3-gallate (EGCG) (positive control), and sinefungin (co-crystal) compounds showed ΔG values −9.34, 
−10.95, −7.95, −11.01, −8.78, −8.87, −11.49, −7.98, −5.92, −8.92, −9.17, −8.76, −9.70, and −9.11 kcal/mol, respectively. Cassiamin C, procyanidin B2, 
epicatechin-4-beta-8-epicatechin-3-O-gallate, withanolide, and gallocatechin-4alpha-8-epicatechin compounds had lower ΔG than sinefungin (co-
crystal) and EGCG (positive control) compounds. The results of molecular dynamic simulation of seven selected compounds showed the best overall 
activities were procyanidin B2, epicatechin-4beta-8-epicatechin-3-O-gallate, and gallocatechin-4alpha-8-epi-catechin compounds.
Conclusions: The best overall activities based on molecular docking and molecular dynamic simulation were procyanidin B2, epicatechin-4beta-
8-epicatechin-3-O-gallate, and gallocatechin-4alpha-8-epi-catechin compounds. Amino acid residues that are important for the activity of DNMT1 
inhibitor are Phe1145, Glu1168, Met1169, Cys1191, Glu1266, Ala1579, and Val1580.
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INTRODUCTION
Cancer is a disease characterized by abnormal uncontrolled growth of 
body cells, especially with respect to cell growth and differentiation, 
and can affect other body tissues through the circulatory system and 
the lymphatic system [1,2]. Cancer is one of the leading causes of death 
worldwide. In 2012, about 8.2 million deaths were caused by cancer. 
It has also been estimated that there may be an increase in cancer 
patients in Indonesia, because of lifestyle patterns including increases 
in cigarette use, alcohol consumption, and lack of physical activity. 
One important factor in cancer occurrence is the abnormal epigenetic 
modification of DNA known as hypermethylation [3]. Hypermethylation 
of DNA can lead to the suppression of genes that should not be 
suppressed and is a risk factor for non-communicable diseases such 
as cancer [4-6]. No therapy currently exists that can restore abnormal 
gene expression, which is one of the main cancer risk factors [7]. 
Hypermethylation occurring in suppressor genes is believed to have 
a major role in the process of carcinogenesis through the increased 
expression of DNA methyltransferases (DNMTs) [8]. Therefore, one way 
to restore the function of suppressed genes is to use drugs that act to 
inhibit DNMTs [8,9]. DNMT inhibitors (DNMTis) can take the form of 
nucleoside and non-nucleoside analogs [9-11].
Compounds from natural substances are some of the most promising 
non-nucleoside DNMTi sources because they have high levels of diversity 
and tend to have low toxicity [12,13]. The exploration of natural material 
compounds for their potential use as DNMTis was previously carried 
out by Wilaputraka using the in silico method of molecular docking [6]. 
These results showed that there were 12 chemical compounds from 
Indonesia’s herbal databases that could potentially serve as DNMTis 
based on their binding energies, with binding energies lower than 
a cocrystal ligand [6]. However, this analysis did not clearly examine 
binding stability in space and time. Therefore, it is necessary to simulate 
the molecular dynamics to further investigate the interactions and 
stability of the bindings. In this study, we investigated the interactions 
of DNMT enzymes and potential ligands as DNMTi through molecular 
dynamics simulations. The ligands used were derived from the results 
of a virtual screening of chemical compounds from Indonesian herbal 
databases conducted by Wilaputraka [6]. As a positive control, we used 
epigallocatechin-3-gallate (EGCG), which has been shown to function as 
a non-nucleoside DNMTi [6, 14-16].
METHODS
This study was conducted using tools in the form of hardware and 
software. The hardware used consisted of three primary computers 
(servers) and three secondary computers (clients) with different 
specifications. The first primary (server) computer with Intel® Xeon 
E5620 (Intel® Core™, American) processor (CPU), Nvidia® GeForce 
GTX 780 (Nvidia®, American) graphics processing unit (GPU), and 
random-access memory (RAM) of 32 gigabyte (GB) DDR3. The server 
ran the Ubuntu Linux operating system 12.04 LTS. The second and 
third servers had almost identical specs, Intel® Core™ i7-3770 (Intel® 
Core™, American) CPUs, 16GB of DDR3 RAM, and run 64-bit Debian 7.8 
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Linux operating system. However, both servers used different GPUs. 
The second server used the Nvidia® GeForce GTX 970 (Nvidia®, USA) 
GPU, while the third server used the Nvidia® GeForce GTX 980 (Nvidia®, 
USA) GPU. All servers were connected with internet connection and 
uninterrupted power supply.
The first client computer used Intel® Core™ 2 Quad Q9400 (Intel® Core™, 
USA) CPUs, Nvidia® GeForce GT 9400 (Nvidia®, USA) GPUs, and 4 GB 
of DDR2 RAM. The computer ran the Linux operating system Ubuntu 
12.04 LTS that is equipped with monitor (AOC, China), mouse (Logitech, 
China), and keyboard (HP, China). The second client computer was 
Mac Mini (Apple Inc., USA) with Intel® Core™ i5-2450M (Intel® Core™, 
USA) CPUS, Intel® Iris 1536 MB (Intel® Core™, USA) GPUs, and 8 GB of 
RAM DDR3. The computer ran the Yosemite 10.10 X operating system 
equipped with monitors (AOC, China), as well as a mouse and keyboard 
(Apple Inc., USA). The third client computer was Asus® A46CM (Asus®, 
Taiwan) with Intel® Core™ i5-3317U (Intel® Core™, American) CPU 
specifications, Nvidia® GeForce GT 635M (Nvidia®, USA) GPUs, and 8 
GB of RAM DDR3. The computer ran Microsoft Windows 10 Pro 64-bit 
(USA) operating system equipped with Logitech MK240 mouse and 
keyboard (Logitech, China). All clients were connected to an internet 
connection.
The software used for our analyses included OpenBabel (Hutchison 
et al.), AutoDock Tools (Scripps Research Institute, USA), Amber MD 
(University of California, San Francisco, USA), Amber Tools (University 
of California, San Francisco, USA), VMD (University of Illinois at Urbana-
Champaign, USA), PuTTY (UK), LigandScout (InteLigand, Austria), 
and UCSF Chimera (University of California, San Francisco, USA). The 
materials used were a three-dimensional (3D) target macromolecular 
structure and a 3D ligand structure. The 3D structure of DNMT1 
was downloaded from the Research Collaboratory for Structural 
Bioinformatics Protein Data Bank (RCSB PDB, at http://www.rcsb.
org/pdb), with the ID number 3SWR. This structure had a resolution 
of 2.49 Å with a sinefungin cocrystal ligand. The 3D ligand structure 
used was the result of a previous virtual screening study conducted by 
Wilaputraka [6]. The ligands (Table 1) were obtained and downloaded 
from the HerbalDB database, KNApSAcK, ChemSpider, and PubChem.
The first step in our analysis was to search for 3D ligand and target 
macromolecule structures that could be downloaded from the RCSB 
GDP database, HerbalDB, KNApSAcK, PubChem, and ChemSpider. Then, 
preparation and optimization of target ligands and macromolecules 
using OpenBabel, AutoDock Tools, Antechamber, and Sander were 
performed. After that, molecularly docked ligands were made against 
the target macromolecules using the AutoDock Zn method and 
designed specifically for target macromolecules that contain and have 
interactions with zinc atoms. Molecular docking was performed using a 
60×60×60 Å gridbox, centered on the coordinates x=−5.041, y=−0.949, 
and z=31.815, with spacing of 0.375 Å. The molecular docking of the 
ligand compound had a lower binding energy than the crystal ligand 
and the positive control ligand, and we simulated molecular dynamics 
for 20 ns to examine the stability of the compound conformation and 
binding in space and time. Simulation of molecular dynamics was done 
using AMBER 12. The results of molecular dynamics simulations were 
analyzed in terms of root mean square deviation (RMSD), root mean 
square fluctuation (RMSF), hydrogen binding, and binding energy of 




The results from molecular docking of the ligand to DNMT1 
macromolecule using the AutoDock Zn method (Table 2) found five 
compounds whose binding affinity and inhibitor constant Ki were 
lower than those of the crystalline ligand (sinefungin) and the positive 
control ligand (EGCG). We refer to these as ligand A (cassiamin C), ligand 
B (procyanidin B2), ligand D (epicatechin-4beta-8-epicatechin-3-O-
gallate), ligand G (withanolide), and ligand K (gallocatechin-4alpha-
8-epicatechin). Thus, we selected these ligands to perform molecular 
dynamics simulations for their potential to be DNMTis. Negative 
bonding energy of a compound to the target macromolecule indicates 
that the energy required by the ligand to bind to the macromolecule 
is lower, while a low value of the inhibition constant Ki indicates 
inhibitory activity of the ligand toward the target protein.
Molecular dynamics simulations
RMSD
In the molecular dynamics simulation of ligand compound with 
DNMT1 for 20 ns, the RMSD fluctuation showed that the sinefungin 
cocrystal (SFG) ligand was stable at 1.5 Å within 2 ns (Fig. 1). At 13 ns, 
the RMSD value increased to 2 Å; however, after 14.5 ns, the system 
returned to stability at RMSD 1.5 Å. The same happened with the ligand 
B (procyanidin B2), which started stable at 2 Å RMSD within 4.5 ns, 
increased in RMSD to 2.5 Å at 13 ns, and then returned to stability at 2 Å 
RMSD after 14.5 ns. The ligand D (epicatechin-4beta-8-epi-catechin-3-
O-gallate) showed similar behavior, in which the RMSD values were 
stable at below 2 Å within 3 ns. However, at 12 ns, the system continued 
to increase in RMSD value up to 3 Å. After the system passed 19 ns, the 
system returned to stable on RMSD 2 Å up to 20 ns. The positive control 
EGCG ligand showed a stable RMSD value at 2 Å within 13.5 ns and 
continued to stabilize up to 20 ns. A similar thing happened with ligand 
A (cassiamin C), which started stable at RMSD 1.5 Å within 17 ns and 
kept stable up to 20 ns. Ligand G (withanolide) also behaved similarly in 
which the RMSD value began to stabilize at below 2 Å within 10 ns and 
continue to stabilize up to 20 ns. The ligand K (gallocatechin-4alpha-
8-epicatechin) behaved differently, where the RMSD values began to 
stabilize at 2 Å within 6.5 ns. At 15 ns, the RMSD value continued to 
increase up to 2.5 Å, and the system returned to stable at RMSD 2 Å after 
16 ns. However, at 18.5 ns, the RMSD value increased above 2.5 Å and 
the system did not return to stability until the 20-ns simulation time 
was complete.
An increase in RMSD value indicates the effect of time on binding 
stability. Thus, it was necessary to lengthen the simulation time to see 
if the molecular dynamics further changed in terms of the stability of 
conformational compounds. In addition, one limitation of this study was 
that simulations were only performed at room temperature settings of 
27°C (or 300 K). Thus, we could not examine changes in the stability of 
conforming compounds at different temperatures. Therefore, in future 
work, it will be necessary to simulate molecular dynamics at different 
temperatures, such as the human body temperature of ±37°C, where 
drug-receptor reactions and interactions occur, or higher temperatures.
RMSF
High values of RMSF occurred at amino acid residues 640–700, 840–
880, 940–1020, 1080–1120, 1460–1500, and 1590–1600 (Fig. 2). 
Amino acid residues with high RMSF values are highly flexible and 














EGCG Epigallocatechin-3-gallate (EGCG) (Positive Control)
SFG Sinefungin (Co-crystal ligand)
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Fig. 1: Graph of root mean square deviation fluctuations in molecular dynamics simulations of ligand compounds with DNA 
methyltransferase 1 for 20 ns
Fig. 2: Graph of root mean square deviation fluctuations in molecular dynamics simulations of ligand compounds with DNA 
methyltransferase 1 for 20 ns
tend to be unstable. In addition, in these residues, the ligand was most 
likely to change position. The active sites of ligands on the amino acid 
residues Phe1145, Ser1146, Gly1147, Gly1149, Gly1150, Leu1151, 
Glu1168, Met1169, Trp1170, Asp1190, Cys1191, Pro1225, Leu1247, 
Glu1266, Asn1578, Ala1579, and Val1580 showed lower RMSF values. 
This indicates that these amino acid residues provided lower flexibility, 
and the interaction between the ligand and the residue tended to be 
stable.
Hydrogen bonds
The SFG cocrystal ligand (sinefungin) and ligand D (epicatechin-4beta-8-
epicatechin-3-O-gallate) had hydrogen bonds in the range of 20–30. The 
ligand B (procyanidin B2) had a hydrogen bond in the range of 15–30. 
The positive control EGCG ligand and ligand K (gallocatechin-4alpha-8-
epi-catechin) had hydrogen bonds in the range of 10–20. The ligand A 
(cassiamin C) had a hydrogen bond in the range of 5–10, while the ligand G 
(withanolide) had the fewest hydrogen bonds, in the range of 0–5 (Fig. 3).
In terms of the percentage of hydrogen bond occupancy that occurred 
during the molecular dynamics simulation, all of the ligands occupied 
the side of the corresponding active sites and showed stable hydrogen 
bonds on the active residues Phe1145, Ser1146. Gly1147, Glu1168, 
Asp1190, Cys1191, Glu1266, and Asn1578 (Table 3). However, for 
the ligand G (withanolide) and ligand K (gallocatechin-4alpha-8-
epicatechin), the hydrogen bonds did not show a stable occupancy 
value in active residues but were stable in the non-active amino 
acid residues Met696, Gly1223, Cys1226, Asn1267, and Gln1575. 
The same amino acid residual involvement showed the extent of the 
ligand binding tendency to the macromolecule. The occupancy result 
of ligand A (cassiamin C), ligand B (procyanidin B2), and ligand D 
(epicatechin-4beta-8-epicatechin-3-O-gallate) showed similarities with 
EGCG (positive control) compounds and sinefungin (co-crystal ligand) 
because they had a common binding site. This suggests that these ligand 
compounds most likely have similar activity to EGCG and sinefungin as 
compound inhibitors of the enzyme DNMT1.
MMPBSA/MMGBSA
The result of calculation of binding energy by MMPBSA/MMGBSA 
method (Table 2) showed that the value of binding energy resulted 
from dynamic simulation with MMPBSA/MMGBSA was always lower 
than binding energy of molecular docking value, since the calculation 
method of ΔG with molecular dynamics had smaller calculation error 
value (accurate). In addition, from MMGBSA results obtained three 
ligands that had lower binding energy than EGCG-positive control ligand, 
the ligands were ligand B (procyanidin B2), ligand D (epicatechin-
4beta-8-epicatechin-3-O-gallate), and ligand K (gallocatechin-4alpha-
8-epicatechin). From MMPBSA results obtained, four ligands that had 
lower binding energy than EGCG-positive control ligand, were ligand 
A (cassiamin C), ligand B (procyanidin B2), ligand D (epicatechin-
4beta-8-epicatechin-3-O-gallate), and ligand K (gallocatechin-4alpha-
8-epicatechin). It demonstrated the potency of these ligands to be able 
to have activity similar as EGCG-positive control ligand that had proven 
in silico and in vitro had activity as a non-nucleoside DNMTi [6,14-16].
The result of calculation of MMPBSA/MMGBSA binding energy on 
ligand G (withanolide) did not show lower binding energy value than 
EGCG-positive control ligand. However, it did not rule out that the 
compound of withanolide ligand could have thr activity as DNMTi 
similar with EGCG-positive control ligand, since the binding energy 
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value in the ligand did not differ greatly with the binding energy value 
in the EGCG-positive control ligand.
DISCUSSION
From the results of molecular dynamics simulations on the DNMT1 
macromolecule (Table 2), we identified three compounds with the best 
activity: Procyanidin B2, epicatechin-4beta-8-epicatechin-3-O-gallate, 
and gallocatechin-4-alpha-8-epicatechin. These three compounds 
showed a stable bond on the active residue (binding site) based on 
the RMSD and RMSF values. In addition, these three compounds had a 
number of hydrogen bonds similar to or greater than the EGCG-positive 
control ligand, had a high occupancy hydrogen bond, and belonged to 
a very strong category of hydrogen bonding (above 50%). Where the 
formation of hydrogen bonds with amino acids on the active (binding) 
Fig. 3: Graph of fluctuations in the number of hydrogen bonds in molecular dynamics simulations of ligand compounds with DNA 
methyltransferase 1 for 20 ns in five moving average periods
Table 3: Percentage occupancy of hydrogen binding of macromolecular ligands complex
Code Compounds Donor Acceptor Binding distance (Å) Occupancy (%)
A Cassiamin C Arg1574-Side-NH1 Lig-Side-O3 2.169 52.35
Lig-Side-O6 Glu1168-Side-OE1 1.952 91.95
Lig-Side-O7 Glu1168-Side-OE1 1.954 92.20
Phe1145-Main-N Lig-Side-O7 2.698 91.65
B Procyanidin B2 Cys1191-Main-N Lig-Side-O6 2.236 89.75
Lig-Side-O11 Gln1227-Side-OE1 1.783 51.85
Lig-Side-O1 Phe1145-Main-O 1.848 86.55
Lig-Side-O9 Glu1168-Side-OE1 1.650 99.75
Lig-Side-O9 Glu1168-Side-OE2 2.128 58.90
Lig-Side-O8 Gly1147-Main-O 1.713 78.80
Lig-Side-O2 Glu1266-Side-OE1 1.723 98.85
Lig-Side-O3 Glu1266-Side-OE1 1.637 100.00
Arg1312-Side-NH1 Lig-Side-O3 3.194 63.05
Cys1191-Side-SG Lig-Side-O6 2.375 54.80
D Epicatechin-4beta-8-epicatechin-3-O-gallate Cys1226-Main-N Lig-Side-O12 2.478 91.35
Cys1191-Main-N Lig-Side-O3 2.314 85.85
Lig-Side-O15 Gln1227-Side-OE1 1.645 91.80
Lig-Side-O7 Glu698-Side-OE2 1.683 89.40
Lig-Side-O12 Asn1267-Side-OD1 2.194 95.85
Lig-Side-O2 Glu1168-Side-OE2 1.777 99.90
Lig-Side-O5 Glu1168-Side-OE1 1.734 100.00
Lig-Side-O1 Gly1223-Main-O 1.800 99.90
Lig-Side-O4 Asp1190-Side-OD2 1.847 100.00
Lig-Side-O3 Asp1190-Side-OD2 1.716 99.95
Lig-Side-O4 Asp1190-Side-CG 3.251 73.65
G Withanolide Gly1223-Main-N Lig-Side-O1 1.921 66.35
K Gallocatechin-4alpha-8-epicatechin Lig-Side-O1 Gln1575-Main-O 1.667 97.65
Cys1226-Main-N Lig-Side-O8 4.357 81.10
Lig-Side-O8 Asn1267-Side-OD1 2.424 82.90
Met696-Main-N Lig-Side-O9 3.348 50.25
EGCG Epigallo-catechin-3-gallate (positive control) Asn1267-Side-CA Lig-Side-O3 3.079 78.20
Lig-Side-O2 Gly1223-Main-O 1.699 98.05
Lig-Side-O7 Gln1575-Main-O 1.904 91.35
Lig-Side-O3 Glu1266-Side-OE1 1.748 100.00
Cys1148-Main-N Lig-Side-O7 2.730 57.25
SFG Sinefungin
(co-crystal ligand)
Lig-Side-O2 Glu1168-Side-CD 1.474 96.00
Lig-Side-CD Phe1145-Main-O 4.615 53.00
Lig-Side-N6 Asp1190-Side-OD2 1.623 97.50
Lig-Main-CA Ser1146-Main-O 3.818 72.70
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site was the mechanism of the action of non-nucleoside DNMTi [6, 14]. 
Then, from the calculation of binding energy by MMPBSA/MMGBSA, the 
three compounds also had lower binding energy than EGCG-positive 
control ligand, which means that these three compounds had the similar 
or even better potency from EGCG that had proven in silico and in vitro 
had the activity as a non-nucleoside DNMTi [6,14-16]. In addition, 
from the visualization of ligand interaction with metromagnetic DNA 
macromolecule 1 (DNMT1), the three compounds also showed the 
interaction of active residue (binding) corresponding to the active 
residue (binding) in the sequence (RCSB GDP). Further research is 
needed, both in vitro and in vivo, to test the inhibitory activity of ligand 
compounds on DNMT enzymes.
CONCLUSIONS
Cassiamin C compounds, procyanidin B2, epicatechin-4beta-8-
epicatechin-3-O-gallate, withanolide, and gallocatechin-4alpha-8-
epicatechin had lower binding energy values/ΔG than sinefungin 
(co-crystal) and EGCG (positive controls). Thus, molecular dynamics 
simulations showed the best overall activity of procyanidin B2, 
epicatechin-4beta-8-epicatechin-3-O-gallate, and gallocatechin-4alpha-
8-epicatechin. Amino acid residues that were important for the activity 
of DNMT1 inhibitors were Phe1145, Glu1168, Met1169, Cys1191, 
Glu1266, Ala1579, and Val1580.
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